ARQT vs BB · rev $196.5M vs P/E 117, rev $549.1M
Arcutis Biotherapeutics Inc (ARQT) versus BlackBerry Ltd (BB) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
ARQT currently screens at market cap $1.64B. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Not investment advice. Open the ARQT and BB stock pages for the full models.
Not investment advice.